Skip to content
10-Q

Quarterly Report

BIOMIMETIC THERAPEUTICS, INC.

0001144204-12-027159

← back to feed
Filed
May 9, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 4, 2012 28.2M sh
Capex Q1 2012 · Mar 31, 2012 $9.33K
Capex Q1 2012 · Mar 31, 2011 $692.62K
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$6.88M
Operating Cash Flow Q1 2012 · Mar 31, 2011 −$7.88M
Short Term Investments Q1 2012 · Mar 31, 2012 $34.06M
Short Term Investments Q1 2012 · Dec 31, 2011 $42.95M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $20.45M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $18.5M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $24.98M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $11.63M
Stockholders Equity Q1 2012 · Mar 31, 2012 $48.81M
Stockholders Equity Q1 2012 · Dec 31, 2011 $54.01M
Current Liabilities Q1 2012 · Mar 31, 2012 $4.03M
Current Liabilities Q1 2012 · Dec 31, 2011 $6.52M
Total Liabilities Q1 2012 · Mar 31, 2012 $18.13M
Total Liabilities Q1 2012 · Dec 31, 2011 $20.87M
Current Assets Q1 2012 · Mar 31, 2012 $59.01M
Current Assets Q1 2012 · Dec 31, 2011 $66.67M
Total Assets Q1 2012 · Mar 31, 2012 $66.94M
Total Assets Q1 2012 · Dec 31, 2011 $74.89M
Sga Expense Q1 2012 · Mar 31, 2012 $3.45M
Sga Expense Q1 2012 · Mar 31, 2011 $4.02M
Rd Expense Q1 2012 · Mar 31, 2012 $2.77M
Rd Expense Q1 2012 · Mar 31, 2011 $4.08M
Net Income Q1 2012 · Mar 31, 2012 −$6.12M
Net Income Q1 2012 · Mar 31, 2011 −$7.95M
Operating Income Q1 2012 · Mar 31, 2012 −$6.14M
Operating Income Q1 2012 · Mar 31, 2011 −$7.99M
Revenue Q1 2012 · Mar 31, 2012 $466.38K
Revenue Q1 2012 · Mar 31, 2011 $398.69K